PMID: 10655437Feb 3, 2000Paper

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Journal of the National Cancer Institute
P TherasseS G Gwyther

Abstract

Anticancer cytotoxic agents go through a process by which their antitumor activity-on the basis of the amount of tumor shrinkage they could generate-has been investigated. In the late 1970s, the International Union Against Cancer and the World Health Organization introduced specific criteria for the codification of tumor response evaluation. In 1994, several organizations involved in clinical research combined forces to tackle the review of these criteria on the basis of the experience and knowledge acquired since then. After several years of intensive discussions, a new set of guidelines is ready that will supersede the former criteria. In parallel to this initiative, one of the participating groups developed a model by which response rates could be derived from unidimensional measurement of tumor lesions instead of the usual bidimensional approach. This new concept has been largely validated by the Response Evaluation Criteria in Solid Tumors Group and integrated into the present guidelines. This special article also provides some philosophic background to clarify the various purposes of response evaluation. It proposes a model by which a combined assessment of all existing lesions, characterized by target lesions (to be meas...Continue Reading

Associated Clinical Trials

References

Aug 1, 1990·Statistics in Medicine·E A Gehan, M A Schneiderman
Jan 1, 1981·Cancer·A B MillerA Winkler
Mar 24, 1999·Journal of the National Cancer Institute·K JamesP Therasse

❮ Previous
Next ❯

Citations

Feb 13, 2001·AJR. American Journal of Roentgenology·S Saini
Aug 8, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A Poveda
Sep 20, 2001·Journal of the National Cancer Institute·K E WarrenF M Balis
Jul 13, 2002·Expert Review of Anticancer Therapy·A L Thomas, W P Steward
May 23, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Morihiko Kimura, Takeshi Tominaga
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ronald FeldUNKNOWN Multinational Association for Supportive Care in Cancer
Jan 15, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Junichi KurebayashiUNKNOWN Tumor Marker Study Group of the Japanese Breast Cancer Society, Japan
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeremy J ErasmusReginald F Munden
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katherine K MatthayJean Michon
Sep 10, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew P GoetzRichard M Goldberg
Aug 2, 2003·Radiology·S Nahum GoldbergUNKNOWN International Working Group on Image-Guided Tumor Ablation
Sep 5, 2003·Radiology·Jane P KoDavid P Naidich
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Micaela HernbergHeikki joensuu
Sep 23, 2003·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Benjamin SolomonRodney Hicks
Dec 17, 2003·Bone Marrow Transplantation·A HoriY Takaue
Dec 6, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A Poveda
Sep 23, 2003·The Journal of Urology·Walter M StadlerNicholas J Vogelzang
Mar 23, 2004·Annals of the New York Academy of Sciences·Tarik BelhocinePierre Rigo
Jan 31, 2004·Technology in Cancer Research & Treatment·Tarik BelhocineFrancis G Blankenberg
Feb 3, 2004·Journal of Surgical Oncology·Tomohiko AiharaYuichi Takatsuka
Mar 18, 2004·Journal of the National Cancer Institute·Gordon J S RustinJan Vermorken
Apr 1, 2004·Head & Neck·Sandro PorcedduLester Peters
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Jun 29, 2004·Journal of Magnetic Resonance Imaging : JMRI·Milica MedvedWalter M Stadler
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Van CutsemD Von Hoff
Aug 5, 2004·Journal of the National Cancer Institute·Federico CappuzzoLucio Crinò
Sep 17, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Aminah JatoiCharles L Loprinzi
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bo GronlundHeine H Hansen
Sep 28, 2004·Cancer Immunology, Immunotherapy : CII·Peter HerseyHeather Johnson
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antoinette R TanSandra M Swain
Oct 16, 2004·Drugs·James E Frampton, Stephanie E Easthope
Jun 24, 2004·Toxicologic Pathology·Eugenia Floyd, Teresa M McShane
Jul 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William L DahutWilliam D Figg
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Feb 12, 2005·Internal Medicine Journal·R SharmaM Millward
Dec 25, 2004·Journal of Cancer Research and Clinical Oncology·Uwe WollinaErich Köstler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.